Arkema (OTCMKTS:ARKAY) Upgraded by Barclays to "Hold" Rating

Key Points

• Barclays upgraded Arkema from “strong sell” to “hold,” joining a broader analyst consensus of “Hold” supported by one Buy, six Hold, and one Sell rating.
• Arkema reported quarterly EPS of $1.98, exceeding the $1.86 analyst estimate, while revenue of $2.79 billion fell short of the $2.86 billion consensus.
• ARKAY opened at $71.81, with a $5.46 billion market capitalization and a 52-week trading range of $56.28 to $79.36.

Arkema (OTCMKTS:ARKAY - Get Free Report) was upgraded by investment analysts at Barclays from a "strong sell" rating to a "hold" rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

ARKAY has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Arkema in a report on Tuesday, June 23rd. The Goldman Sachs Group cut shares of Arkema from a "buy" rating to a "neutral" rating in a research note on Monday, June 8th. Zacks Research upgraded shares of Arkema from a "strong sell" rating to a "hold" rating in a research note on Monday, May 4th. Berenberg Bank downgraded shares of Arkema from a "strong-buy" rating to a "hold" rating in a report on Monday, April 20th. Finally, Sanford C. Bernstein raised shares of Arkema from a "strong sell" rating to a "hold" rating in a report on Monday, April 20th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold".

Arkema Stock Performance

OTCMKTS ARKAY opened at $71.81 on Wednesday. The stock has a market capitalization of $5.46 billion, a P/E ratio of 247.62 and a beta of 0.85. Arkema has a 52-week low of $56.28 and a 52-week high of $79.36. The firm has a 50-day moving average price of $65.99 and a 200 day moving average price of $67.92. The company has a quick ratio of 1.64, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Arkema (OTCMKTS:ARKAY - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.98 EPS for the quarter, beating analysts' consensus estimates of $1.86 by $0.12. Arkema had a net margin of 0.67% and a return on equity of 4.27%. The firm had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.86 billion. Equities research analysts expect that Arkema will post 3.67 EPS for the current year.

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source